Jpmorgan Chase & CO Zentek Ltd. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Zentek Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 20,000 shares of ZTEK stock, worth $17,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$17,400
Previous $21,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$1.19 - $1.66 $23,800 - $33,200
20,000 New
20,000 $25,000
Q2 2022

Aug 11, 2022
SELL
$1.52 - $3.08 $12,312 - $24,948
-8,100 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$1.93 - $3.92 $15,633 - $31,752
8,100 New
8,100 $25,000

Others Institutions Holding ZTEK

# of Institutions
16
Shares Held
1.47M
Call Options Held
0
Put Options Held
0
View Full List

About Zentek Ltd.

ZTEK Quotes by TradingView
  • Ticker ZTEK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 99,363,104
  • Market Cap $86.4M
  • Description
  • Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detec...
More about ZTEK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email